In this free webinar, learn how the fat attenuation index (FAI) score serves as a validated imaging biomarker for coronary inflammation in atherosclerotic cardiovascular disease (ASCVD) trials. Attendees will understand how imaging endpoints like FAI can improve early disease detection, patient stratification and endpoint responsiveness. The featured speakers will share practical insights into site selection, rater training and imaging data quality assurance.
TORONTO, June 5, 2025 /PRNewswire-PRWeb/ -- As cardiovascular clinical trials evolve, imaging biomarkers have become essential tools for enriching patient populations, evaluating therapeutic response and accelerating study timelines. Among these, the detection of coronary inflammation is emerging as a powerful means of advancing research in atherosclerotic cardiovascular disease (ASCVD).
In this webinar, experts will explore the growing role of imaging endpoints in ASCVD trials, with a focus on the fat attenuation index (FAI) score, a groundbreaking imaging biomarker of coronary inflammation. Attendees will explore how the integration of FAI-based endpoints is set to transform clinical trials in ASCVD.
Attendees will gain an understanding of the scientific basis behind FAI and its validation in large-scale studies. They will learn how this technology enables early disease detection, patient risk stratification and more responsive endpoints. The panel will offer practical guidance on incorporating imaging endpoints into the next generation of ASCVD trials.
The featured speakers will also share insights into best practices in trial planning and execution, including site selection, training and certification, strategies for imaging oversight and data quality assurance.
Register for this webinar today to gain actionable insights on leveraging imaging endpoints to strengthen development strategies in cardiovascular disease trials.
Join Charalambos Antoniades, MD, PhD, FRCP, FESC, Co-Founder and Chief Scientific Officer, Caristo Diagnostics; Rina Ariga, MBBS, DPhil, MRCP, Medical Director, Medpace; and Andrea Flannery, PhD, Director, Clinical Trial Management, Medpace, for the live webinar on Friday, June 20, 2025, at 10am EDT (4pm CEST/EU-Central).
For more information, or to register for this event, visit Advancing Atherosclerotic Cardiovascular Disease Trials Through Innovative Imaging Endpoints.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], www.xtalks.com
SOURCE Xtalks
Share this article